The immune system, by and large, plays a primary role to minimize and/or prevent infection, in general, and periodontal disease, in particular. We propose that immunoregulatory abnormalities contribute to the pathogeneisis of and susceptibility to periodontal disease. The fundamental hypothesis of our studies is that periodontal pathogens produce immunosuppressive proteins (ISP) that mediate local and/or systemic immunosuppression, thereby enhancing their own virulence and/or that of other opportunistic microorganisms. In this regard, our investigations have demonstrated that Actinobacillus actionmycetemcomitans produces an ISP that impairs human T- and B-cell function. We plan to focus this investigation on the A. actinomycetemcomtians ISP which we have shown to be a product of the cytolethal distending toxin (Cdt) operon. We have demonstrated that Cdt acts by inducing cell cycle arrest of human T-cells in the G2 phase which eventually leads to cell death via activation of the apoptotic cascade. More recently, we have demonstrated that the A. actinomycetemcomitans Cdt functions as an AB2 toxin where CdtB is the active (A) unit and the complex of CdtA and CdtC comprise the binding (B) unit. Furthermore, we have demonstrated that membrane lipid microdomains and signaling pathways involving protein kinase C (PKC) activation are critical to the mode of action of the toxin. The objectives of this proposal are: (1) define the role of membrane lipid microdomains in relation to the cascade of events responsible for toxin-induced G2 arrest and cell death;(2) to determine the relationship between CdtB structure and function. The study is divided into 4 specific aims: (1) To determine if Cdt holotoxin interaction with host cell plasma membranes requires cholesterol;(2) To determine the relationship between membrane microdomains, cellugyrin and CdtB internalization;(3) To determine the role of PKC activation and its relationship to membrane microdomains in Cdt-induced G2 arrest and apoptosis;and (4) To determine if CdtB exhibits phosphatidylinositol (PI) phosphatase activity and, if so, determine if the activity is critical to the toxins mode of action. It is anticipated that these studies will lead to a more detailed understanding of Cdt and provide: (1) important insight into the pathogenesis of disease caused by Cdt-producing bacteria and (2) a rationale on which therapeutic intervention may be developed to prevent or limit disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Research Project (R01)
Project #
5R01DE006014-27
Application #
7578227
Study Section
Oral, Dental and Craniofacial Sciences Study Section (ODCS)
Program Officer
Lunsford, Dwayne
Project Start
1982-08-01
Project End
2011-02-28
Budget Start
2009-03-01
Budget End
2010-02-28
Support Year
27
Fiscal Year
2009
Total Cost
$366,783
Indirect Cost
Name
University of Pennsylvania
Department
Pathology
Type
Schools of Dentistry
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Boesze-Battaglia, Kathleen; Walker, Lisa P; Dhingra, Anuradha et al. (2017) Internalization of the Active Subunit of the Aggregatibacter actinomycetemcomitans Cytolethal Distending Toxin Is Dependent upon Cellugyrin (Synaptogyrin 2), a Host Cell Non-Neuronal Paralog of the Synaptic Vesicle Protein, Synaptogyrin 1. Front Cell Infect Microbiol 7:469
Leonard, Stephanie A; Petito, Lucia C; Stephansson, Olof et al. (2017) Weight gain during pregnancy and the black-white disparity in preterm birth. Ann Epidemiol 27:323-328.e1
Scuron, Monika D; Boesze-Battaglia, Kathleen; Dlaki?, Mensur et al. (2016) The Cytolethal Distending Toxin Contributes to Microbial Virulence and Disease Pathogenesis by Acting As a Tri-Perditious Toxin. Front Cell Infect Microbiol 6:168
Shenker, B J; Walker, L P; Zekavat, A et al. (2016) Lymphoid susceptibility to the Aggregatibacter actinomycetemcomitans cytolethal distending toxin is dependent upon baseline levels of the signaling lipid, phosphatidylinositol-3,4,5-triphosphate. Mol Oral Microbiol 31:33-42
Shenker, Bruce J; Boesze-Battaglia, Kathleen; Scuron, Monika Damek et al. (2016) The toxicity of the Aggregatibacter actinomycetemcomitans cytolethal distending toxin correlates with its phosphatidylinositol-3,4,5-triphosphate phosphatase activity. Cell Microbiol 18:223-43
Boesze-Battaglia, Kathleen; Walker, Lisa P; Zekavat, Ali et al. (2015) The Aggregatibacter actinomycetemcomitans Cytolethal Distending Toxin Active Subunit CdtB Contains a Cholesterol Recognition Sequence Required for Toxin Binding and Subunit Internalization. Infect Immun 83:4042-55
Shenker, Bruce J; Ojcius, David M; Walker, Lisa P et al. (2015) Aggregatibacter actinomycetemcomitans cytolethal distending toxin activates the NLRP3 inflammasome in human macrophages, leading to the release of proinflammatory cytokines. Infect Immun 83:1487-96
Shenker, Bruce J; Walker, Lisa P; Zekavat, Ali et al. (2014) Blockade of the PI-3K signalling pathway by the Aggregatibacter actinomycetemcomitans cytolethal distending toxin induces macrophages to synthesize and secrete pro-inflammatory cytokines. Cell Microbiol 16:1391-404
Shenker, Bruce J; Ali, Hydar; Boesze-Battaglia, Kathleen (2011) PIP3 regulation as promising targeted therapy of mast-cell-mediated diseases. Curr Pharm Des 17:3815-22
Shenker, Bruce J; Boesze-Battaglia, Kathleen; Zekavat, Ali et al. (2010) Inhibition of mast cell degranulation by a chimeric toxin containing a novel phosphatidylinositol-3,4,5-triphosphate phosphatase. Mol Immunol 48:203-10